Walti, Laura Naëmi; Steinrücken, Julia; Rauch, Andri; Wandeler, Gilles (2018). Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity. Open Forum Infectious Diseases, 5(11), ofy275. Oxford University Press 10.1093/ofid/ofy275
|
Text
Walti_TAFearlyaccess_OFID18.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (300kB) | Preview |
Although the use of tenofovir alafenamide (TAF), a new prodrug of tenofovir, was safe and efficacious in clinical trials, real-world data from multimorbid individuals are scarce. Among 10 persons living with HIV with previous tenofovir disoproxil fumarate-induced nephrotoxicity, renal function remained stable, and proteinuria decreased in several patients after the switch to TAF.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM) 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology |
UniBE Contributor: |
Walti, Laura Naëmi, Steinrücken, Julia, Rauch, Andri, Wandeler, Gilles |
Subjects: |
300 Social sciences, sociology & anthropology > 360 Social problems & social services 600 Technology > 610 Medicine & health |
ISSN: |
2328-8957 |
Publisher: |
Oxford University Press |
Language: |
English |
Submitter: |
Annelies Luginbühl |
Date Deposited: |
13 Dec 2018 13:23 |
Last Modified: |
05 Dec 2022 15:22 |
Publisher DOI: |
10.1093/ofid/ofy275 |
PubMed ID: |
30515426 |
Uncontrolled Keywords: |
antiretroviral therapy chronic kidney disease drug nephrotoxicity tenofovir alafenamide |
BORIS DOI: |
10.7892/boris.122369 |
URI: |
https://boris.unibe.ch/id/eprint/122369 |
Actions (login required)
 |
Edit item |